Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL - Narrative (Details)

v3.21.2
SHARE CAPITAL - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2021
USD ($)
shares
Sep. 30, 2021
$ / shares
shares
Sep. 30, 2020
shares
Jun. 30, 2020
$ / shares
shares
Sep. 30, 2021
$ / shares
shares
Sep. 30, 2020
USD ($)
Aug. 31, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                
Common stock, shares authorized   180,000,000     180,000,000   900,000,000 180,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.001     $ 0.001   $ 0.001 $ 0.001
Common stock, shares issued   11,839,304     11,839,304     11,275,788
Common stock, shares outstanding   11,839,304     11,839,304     11,275,788
Reverse stock split ratio   0.2 0.2          
Fractional shares issued     0          
Shares issued       156,032        
Share price | $ / shares       $ 4.00        
Outstanding principal | $           $ 60,000,000    
Shares issued on conversion of debt         13,384      
Sentry Neuromonitoring, LLC                
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                
Value of common stock issuable | $ $ 1,625,000              
Common stock issuable 237,226              
Held in escrow, Value | $ $ 650,000              
Held in escrow, Shares 94,891              
Common stock lock up period 12 months